Showing results (1301-1310 of 1,447) with videos related to
Sort By:
Pageof 145
Journal of the American College of Radiology : JACR|January 6, 2015
ACR Appropriateness Criteria Dementia and Movement DisordersFranz J Wippold, Douglas C Brown, Daniel F Broderick, et al.Nature Aging|March 30, 2023
Human striatal glia differentially contribute to AD- and PD-specific neurodegenerationJinbin Xu, Huifangjie L Farsad, Yiran Hou, et al.Parkinsonism & Related Disorders|May 30, 2025
Diagnostic accuracy of screening tools for depression and anxiety in cervical dystoniaDavide Martino, Mehrafarin Ramezani, Steven Bellows, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guidelineSharon H Giordano, Sarah Temin, Jeffrey J Kirshner, et al.Science Translational Medicine|February 7, 2020
<i>APOE</i> genotype regulates pathology and disease progression in synucleinopathyAlbert A Davis, Casey E Inman, Zachary M Wargel, et al.BMJ Quality & Safety|December 10, 2021
Impact of Statewide Prevention and Reduction of <i>Clostridioides difficile</i> (SPARC), a Maryland public health-academic collaborative: an evaluation of a quality improvement interventionClare Rock, Rebecca Perlmutter, David Blythe, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2019
Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence RatesAlice Y Guh, Kelly M Hatfield, Lisa G Winston, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2018
National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast CancerAndrew D Seidman, Louise Bordeleau, Louis Fehrenbacher, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2024
Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trialL A Huppert, D Wolf, C Yau, et al.Journal of the Neurological Sciences|February 1, 2022
Head tremor in cervical dystonia: Quantifying severity with computer visionJeanne P Vu, Elizabeth Cisneros, Ha Yeon Lee, et al.Pageof 145